Prevention of Contrast-Induced Nephropathy

Chapter
First Online:

Abstract

There is no consensus definition of contrast-induced nephropathy (CIN). Commonly used definitions include an increase in serum creatinine of 0.5 mg/dL or a 25% increase above baseline within 48 h of contrast.

Keywords

Sodium Bicarbonate Isotonic Saline Contrast Administration Livedo Reticularis High Dose Protocol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Bibliography

  1. 1.
    Kagan A and D Sheikh-Hamad. Contrast-induced Kidney Injury: Focus on Modifiable Risk Factors and Prophylactic Strategies. Clin Cardiol. 2010; 33(2): 62–66. ® An excellent overview of risk factors, pathophysiology, and prevention of CIN. PubMedCrossRefGoogle Scholar
  2. 2.
    Jawdeh B, AA Kanso, JR Schelling. Evidence-based Approach for Prevention of Radiocontrast-induced Nephropathy. J Hosp Med. 2009 Oct; 4(8): 500–506. ® Another review of CIN with more in-depth discussion of CIN prophylaxis. PubMedCrossRefGoogle Scholar
  3. 3.
    Mehran R, ED Aymong, E Nikolsky, et al. A Simple Risk Score for Prediction of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention: Development and Initial Validation. J Am Coll Cardiol. 2004 Oct 6; 44(7): 1393–1399. ® Provides a method to calculate risk of CIN based on patient risk factors. PubMedGoogle Scholar
  4. 4.
    Mueller C, G Buerkle, HJ Buettner et al. Prevention of contrast media-associated nephropathy. Arch Int Med. 2002; 162: 329–336. ® Prospective randomized controlled trial comparing isotonic saline vs. half-isotonic saline in prevention of contrast induced nephropathy. CrossRefGoogle Scholar
  5. 5.
    Merten GJ, WP Burgess, LV Gray, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate. JAMA 2004; 291: 2328–2334. ® One of the first prospective trials showing IV sodium bicarbonate reduces the risk of CIN. Google Scholar
  6. 6.
    Hoste E, De Waele JJ, Gevaert SA, et al. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant. 2010; 25: 747–758. ® A recent meta-analysis showing reduced rates of CIN when using sodium bicarbonate vs. saline. PubMedCrossRefGoogle Scholar
  7. 7.
    Tepel M, vander Giet M, Schwarzfeld C et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000; 343: 180–4. ® First clinical trial showing benefit of NAC in CIN prevention. PubMedCrossRefGoogle Scholar
  8. 8.
    Trivedi H, S Daram, A Szabo, et al. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am J Med. 2009; 122: 874.e9-874.e15. ® A meta-analysis showing benefit of high dose N-acetylcysteine for CIN prevention. Google Scholar
  9. 9.
    McCullough PA, Bertrand ME, Brinker JA, Stacul F. A meta-analysis of the renal safety of isoosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol. 2006; 48(4): 692–699. ® A meta-analysis showing a lower rate of CIN with iodixanol (isoosmolar contrast) compared with low osmolar contrast media. PubMedCrossRefGoogle Scholar
  10. 10.
    Marenzi G, Marana I, Lauri G et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003; 349: 1333–1340. ® Prospective clinical trial comparing CVVH vs. control to prevent contrast-induced nephropathy. PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of Nephrology, Department of MedicineUniversity of California – San FranciscoSan FranciscoUSA

Personalised recommendations